KYA1797K is primarily researched for its potential in cancer therapy due to its ability to inhibit the Wnt/β-catenin signaling pathway, which is often dysregulated in various cancers. By targeting this pathway, it may help suppress tumor growth and progression. Additionally, it is being explored for its role in neurodegenerative diseases, as modulating Wnt signaling could offer therapeutic benefits in conditions like Alzheimer's disease. Its application in regenerative medicine is also under investigation, particularly in promoting tissue repair and regeneration. Ongoing studies aim to further elucidate its efficacy and safety for clinical use.